Filter Reports by Region
sale
Pembrolizumab Market: Global Opportunity Analysis and Industry Forecast, 2023-2032
Pembrolizumab is a humanized monoclonal antibody used in cancer immunotherapy that treats melanoma, lung cancer, head & neck cancer, Hodgkin lymphoma, and stomach cancer. It is an IgG4 ...
Report Code : A13581 | Category : Life Sciences
